Table 3 |
|||
|
Allelic distributions of HLA-B27 and HLA-C among subsets of psoriatic arthritis |
|||
| HLA |
Oligoarthritis (n = 40) |
Polyarthritis (n = 25) |
Axial disease (n = 35) |
|
|
|||
| Cw*0102 |
5 (12) |
2 (8) |
3 (9) |
| Cw*0202 |
3 (7) |
2 (8) |
3 (9) |
| Cw*0303 |
5 (12) |
3 (12) |
3 (9) |
| Cw*0304 |
2 (5) |
- |
2 (6) |
| Cw*0401 |
12 (30) |
5 (20) |
6 (17) |
| Cw*0501 |
3 (7) |
3 (12) |
3 (9) |
| Cw*0602 |
23 (57) |
15 (60) |
20 (57) |
| Cw*0701 |
8 (20) |
5 (20) |
6 (17) |
| Cw*0702 |
3 (7) |
3 (12) |
11 (31)a |
| Cw*0802 |
- |
1 (4) |
2 (6) |
| Cw*1203 |
2 (5) |
- |
1 (3) |
| Cw*1402 |
2 (5) |
1 (4) |
1 (3) |
| Cw*1502 |
3 (7) |
1 (4) |
1 (3) |
| Cw*1601 |
3 (7) |
- |
1 (3) |
| B27 |
8 (20) |
3 (12) |
19 (54)b |
|
|
|||
|
HLA, human leukocyte antigen. Results in parentheses are percentages. aOdds ratio (OR) 5.0 (95% confidence interval 1.4 to 25.0; p = 0.01); bOR 5.8 (95% confidence interval 2.3 to 14.7; p < 0.0001). |
|||
|
Queiro et al. Arthritis Research & Therapy 2006 8:R185 doi:10.1186/ar2097 |
|||
